ELV
What one share of Elevance Health holds
Hospital and Medical Service Plans
Elevance Health and its direct and indirect subsidiaries, referred to throughout this document as “we,” “us,” “our,” the “Company” or “Elevance Health,” is a leading health company bringing together the concepts of elevate and advance.
Elevance Health’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-09-30; the balance sheet is as of 2026-09-30.
| Sales | $920.13 |
|---|---|
| Profit | $23.43 |
| Capex (buildings and equipment) | $4.93 |
| Free cash flow | $29.70 |
| Dividends | $6.83 |
| Cash and investments | $47.88 |
| Debt | $142.32 |
| Book value | $206.75 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2007 | $101.66 | $5.56 | $0.54 | $6.69 | — | $38.21 |
| 2008 | $117.11 | $4.76 | $0.66 | $4.19 | — | $42.59 |
| 2009 | $135.15 | $9.88 | $0.79 | $5.54 | — | $55.28 |
| 2010 | $141.17 | $6.94 | $1.09 | $2.32 | $0.00 | $63.04 |
| 2011 | $166.29 | $7.25 | $1.42 | $7.82 | $1.00 | $68.62 |
| 2012 | $189.34 | $8.18 | $1.68 | $6.77 | $1.15 | $78.11 |
| 2013 | $233.78 | $8.20 | $2.13 | $7.92 | $1.50 | $84.44 |
| 2014 | $258.39 | $8.99 | $2.50 | $9.29 | $1.75 | $90.45 |
| 2015 | $290.06 | $9.38 | $2.34 | $13.10 | $2.50 | $88.21 |
| 2016 | $316.53 | $9.21 | $2.18 | $10.02 | $2.60 | $95.17 |
| 2017 | $336.22 | $14.35 | $2.95 | $12.67 | $2.70 | $103.49 |
| 2018 | $348.62 | $14.19 | $4.57 | $9.91 | $3.00 | $110.88 |
| 2019 | $400.36 | $18.47 | $4.14 | $19.15 | $3.20 | $125.45 |
| 2020 | $479.23 | $17.98 | $4.01 | $38.01 | $3.80 | $135.28 |
| 2021 | $561.75 | $24.95 | $4.40 | $29.49 | $4.52 | $149.29 |
| 2022 | $644.95 | $24.28 | $4.74 | $29.85 | $5.12 | $152.31 |
| 2023 | $721.74 | $25.22 | $5.46 | $28.50 | $5.92 | $168.64 |
| 2024 | $760.03 | $25.68 | $5.39 | $19.54 | — | $181.62 |
| 2025 | $886.58 | $25.21 | $4.97 | $14.13 | — | $198.81 |